Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family

Journal of Biological Chemistry

Volumn 290, Issue 10, 2015, Pages 5991-6002

  Neidel, Sarah ^a   Maluquer De Motes, Carlos ^a,c   Mansur, Daniel S ^b   Strnadova, Pavla ^a   Smith, Geoffrey L ^a   Graham, Stephen C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CRYSTAL STRUCTURE; HYDROPHOBICITY; MOBILE SECURITY; SURFACE CHEMISTRY; TRANSCRIPTION; VIRUSES;

BCL-2 FAMILY PROTEINS; HYDROPHOBIC INTERACTIONS; HYDROPHOBIC SURFACES; NUCLEAR FACTOR KAPPAB; PHYLOGENETIC ANALYSIS; SEQUENCE IDENTITY; SEQUENCE SIMILARITY; SURFACE GROOVES;

PROTEINS;

PROTEIN BCL 2; UNCLASSIFIED DRUG; VACCINIA VIRUS PROTEIN A49; VIRULENCE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HYDROPHOBICITY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN FOLDING; SEQUENCE ANALYSIS; SURFACE PROPERTY; CHEMISTRY; GENETICS; HEK293 CELL LINE; HUMAN; INNATE IMMUNITY; METABOLISM; PATHOGENICITY; VACCINIA; VACCINIA VIRUS; VIROLOGY; X RAY CRYSTALLOGRAPHY;

HERPESVIRIDAE; POXVIRIDAE; VACCINIA VIRUS;

APOPTOSIS; CRYSTALLOGRAPHY, X-RAY; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; NF-KAPPA B; PHYLOGENY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTO-ONCOGENE PROTEINS C-BCL-2; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84924973587     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.624650     Document Type: Article

References (84)

1. th Ed. (Fields, B. N., Knipe, D. M., and Howley, P. M., eds) pp. 2905-2946, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia
2. Gubser, C., Hué, S., Kellam, P., and Smith, G. L. (2004) Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 85, 105-117
3. Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H., and Smith, G. L. (2012) DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife 1, e00047
4. Walsh, S. R., and Dolin, R. (2011) Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev. Vaccines 10, 1221-1240
5. Mansur, D. S., Maluquer de Motes, C., Unterholzner, L., Sumner, R. P., Ferguson, B. J., Ren, H., Strnadova, P., Bowie, A. G., and Smith, G. L. (2013) Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog. 9, e1003183
6. Oeckinghaus, A., and Ghosh, S. (2009) The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1, a000034
7. Balachandran, S., and Beg, A. A. (2011) Defining emerging roles for NFkappaB in antivirus responses: revisiting the interferon-β enhanceosome paradigm. PLoS Pathog. 7, e1002165
8. β-TrCP1 ubiquitin ligase. Mol. Cell 11, 1445-1456
9. Smith, G. L., Benfield, C. T., Maluquer de Motes, C., Mazzon, M., Ember, S. W., Ferguson, B. J., and Sumner, R. P. (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J. Gen. Virol. 94, 2367-2392
10. van Buuren, N., Burles, K., Schriewer, J., Mehta, N., Parker, S., Buller, R. M., and Barry, M. (2014) EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence. PLoS Pathog. 10, e1004326
11. Aoyagi, M., Zhai, D., Jin, C., Aleshin, A. E., Stec, B., Reed, J. C., and Liddington, R. C. (2007) Vaccinia virus N1L protein resembles a B cell lym-phoma- 2 (Bcl-2) family protein. Protein Sci. 16, 118-124
12. Cooray, S., Bahar, M. W., Abrescia, N. G., McVey, C. E., Bartlett, N. W., Chen, R. A., Stuart, D. I., Grimes, J. M., and Smith, G. L. (2007) Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 88, 1656-1666
13. Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A., Whalen, D. M., Abrescia, N. G., Alderton, D., Owens, R. J., Stuart, D. I., Smith, G. L., and Grimes, J. M. (2008) Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-κB rather than apoptosis. PLoS Pathog. 4, e1000128
14. Kvansakul, M., van Delft, M. F., Lee, E. F., Gulbis, J. M., Fairlie, W. D., Huang, D. C., and Colman, P. M. (2007) A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 25, 933-942
15. Kvansakul, M., Yang, H., Fairlie, W. D., Czabotar, P. E., Fischer, S. F., Perugini, M. A., Huang, D. C., and Colman, P. M. (2008) Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ. 15, 1564-1571
16. González, J. M., and Esteban, M. (2010) A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history. Virol. J. 7, 59
17. Czabotar, P. E., Lessene, G., Strasser, A., and Adams, J. M. (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49-63
18. Maluquer de Motes, C., Cooray, S., Ren, H., Almeida, G. M., McGourty, K., Bahar, M. W., Stuart, D. I., Grimes, J. M., Graham, S. C., and Smith, G. L. (2011) Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog. 7, e1002430
19. Berrow, N. S., Alderton, D., Sainsbury, S., Nettleship, J., Assenberg, R., Rahman, N., Stuart, D. I., and Owens, R. J. (2007) A versatile ligationindependent cloning method suitable for high-throughput expression screening applications. Nucleic Acids Res. 35, e45
20. Teo, H., Perisic, O., González, B., and Williams, R. L. (2004) ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes. Dev. Cell 7, 559-569
21. Bartlett, N., Symons, J. A., Tscharke, D. C., and Smith, G. L. (2002) The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83, 1965-1976
22. Chen, R. A., Jacobs, N., and Smith, G. L. (2006) Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J. Gen. Virol. 87, 1451-1458
23. Walter, T. S., Diprose, J. M., Mayo, C. J., Siebold, C., Pickford, M. G., Carter, L., Sutton, G. C., Berrow, N. S., Brown, J., Berry, I. M., Stewart-Jones, G. B., Grimes, J. M., Stammers, D. K., Esnouf, R. M., Jones, E. Y., Owens, R. J., Stuart, D. I., and Harlos, K. (2005) A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D Biol. Crystallogr. 61, 651-657
24. Holyoak, T., Fenn, T. D., Wilson, M. A., Moulin, A. G., Ringe, D., and Petsko, G. A. (2003) Malonate: a versatile cryoprotectant and stabilizing solution for salt-grown macromolecular crystals. Acta Crystallogr. D Biol. Crystallogr. 59, 2356-2358
25. Kabsch, W. (2010) XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132
26. Winter, G. (2010) xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Cryst. 43, 186-190
27. Vonrhein, C., Blanc, E., Roversi, P., and Bricogne, G. (2007) Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215-230
28. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6, 458-463
29. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501
30. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., and Vagin, A. A. (2011) REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355-367
31. Vagin, A., and Teplyakov, A. (1997) MOLREP: an automated program for molecular replacement. J. Appl. Cryst. 30, 1022-1025
32. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic software. J. Appl. Cryst. 40, 658-674
33. Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., 3rd, Snoeyink, J., Richardson, J. S., and Richardson, D. C. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375-W383
34. Hooft, R. W. W., Vriend, G., Sander, C., and Abola, E. E. (1996) Errors in protein structures. Nature 381, 272-272
35. Finn, R. D., Bateman, A., Clements, J., Coggill, P., Eberhardt, R. Y., Eddy, S. R., Heger, A., Hetherington, K., Holm, L., Mistry, J., Sonnhammer, E. L., Tate, J., and Punta, M. (2014) Pfam: the protein families database. Nucleic Acids Res. 42, D222-D230
36. Kleywegt, G. J., and Jones, T. A. (1997) Detecting folding motifs and similarities in protein structures. Methods Enzymol. 277, 525-545
37. Kelley, L. A., and Sutcliffe, M. J. (1997) OLDERADO: on-line database of ensemble representatives and domains. Protein Sci. 6, 2628-2630
38. Ravantti, J., Bamford, D., and Stuart, D. I. (2013) Automatic comparison and classification of protein structures. J. Struct. Biol. 183, 47-56
39. Huson, D. H., and Scornavacca, C. (2012) Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks. Syst. Biol. 61, 1061-1067
40. Bond, C. S., and Schüttelkopf, A. W. (2009) ALINE: a WYSIWYG proteinsequence alignment editor for publication-quality alignments. Acta Crystallogr. D Biol. Crystallogr. 65, 510-512
41. Gloeckner, C. J., Boldt, K., Schumacher, A., Roepman, R., and Ueffing, M. (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7, 4228-4234
42. Ember, S. W., Ren, H., Ferguson, B. J., and Smith, G. L. (2012) Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J. Gen. Virol. 93, 2098-2108
43. Falkner, F. G., and Moss, B. (1990) Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64, 3108-3111
44. r 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390
45. Lama, D., and Sankararamakrishnan, R. (2010) Identification of core structural residues in the sequentially diverse and structurally homologous Bcl-2 family of proteins. Biochemistry 49, 2574-2584
46. Krissinel, E., and Henrick, K. (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256-2268
47. Kvansakul, M., and Hinds, M. G. (2013) Structural biology of the Bcl-2 family and its mimicry by viral proteins. Cell Death Dis. 4, e909
48. Wang, G., Barrett, J. W., Nazarian, S. H., Everett, H., Gao, X., Bleackley, C., Colwill, K., Moran, M. F., and McFadden, G. (2004) Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J. Virol. 78, 7097-7111
49. Day, C. L., Smits, C., Fan, F. C., Lee, E. F., Fairlie, W. D., and Hinds, M. G. (2008) Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 380, 958-971
50. Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., Thompson, C. B., and Fesik, S. W. (1997) Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986
51. Fedosyuk, S., Grishkovskaya, I., de Almeida Ribeiro, E., Jr., and Skern, T. (2014) Characterization and structure of the vaccinia virus NF-κB antagonist A46. J. Biol. Chem. 289, 3749-3762
52. Oda, S., Schröder, M., and Khan, A. R. (2009) Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure 17, 1528-1537
53. Krissinel, E., and Henrick, K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797
54. Benfield, C. T., Mansur, D. S., McCoy, L. E., Ferguson, B. J., Bahar, M. W., Oldring, A. P., Grimes, J. M., Stuart, D. I., Graham, S. C., and Smith, G. L. (2011) Mapping the IκB kinase β (IKKβ)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKβ-mediated activation of nuclear factor κB. J. Biol. Chem. 286, 20727-20735
55. Finn, R. D., Clements, J., and Eddy, S. R. (2011) HMMER web server: interactive sequence similarity searching. Nucleic Acids Res. 39, W29-W37
56. Söding, J., Remmert, M., Biegert, A., and Lupas, A. N. (2006) HHsenser: exhaustive transitive profile search using HMM-HMM comparison. Nucleic Acids Res. 34, W374-W378
57. Rossmann, M. G., and Argos, P. (1976) Exploring structural homology of proteins. J. Mol. Biol. 105, 75-95
58. Veyer, D. L., Maluquer de Motes, C., Sumner, R. P., Ludwig, L., Johnson, B. F., and Smith, G. L. (2014) Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection. J. Gen. Virol. 95, 2757-2768
59. Chen, R. A., Ryzhakov, G., Cooray, S., Randow, F., and Smith, G. L. (2008) Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4, e22
60. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., and O'Neill, L. A. (2003) The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197, 343-351
61. Stack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., and Bowie, A. G. (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201, 1007-1018
62. Schröder, M., Baran, M., and Bowie, A. G. (2008) Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKε-mediated IRF activation. EMBO J. 27, 2147-2157
63. DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A., and Marshall, W. L. (2004) Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors. J. Biol. Chem. 279, 36570-36578
64. Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501
65. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490
66. Wang, Y., and Tjandra, N. (2013) Structural insights of tBid, the caspase- 8-activated Bid, and its BH3 domain. J. Biol. Chem. 288, 35840-35851
67. Bergsten, J. (2005) A review of long-branch attraction. Cladistics 21, 163-193
68. Bour, S., Perrin, C., Akari, H., and Strebel, K. (2001) The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with β TrCP-mediated degradation of IκB. J. Biol. Chem. 276, 15920-15928
69. Douglas, J. L., Viswanathan, K., McCarroll, M. N., Gustin, J. K., Früh, K., and Moses, A. V. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a βTrCP-dependent mechanism. J. Virol. 83, 7931-7947
70. Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. (1998) A novel human WD protein, h-β TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565-574
71. Stack, J., Hurst, T. P., Flannery, S. M., Brennan, K., Rupp, S., Oda, S., Khan, A. R., and Bowie, A. G. (2013) Poxviral protein A52 stimulates p38 mitogen-activated protein kinase (MAPK) activation by causing tumor necrosis factor receptor-associated factor 6 (TRAF6) self-association leading to transforming growth factor β-activated kinase 1 (TAK1) recruitment. J. Biol. Chem. 288, 33642-33653
72. Smith, G. L., Chan, Y. S., and Howard, S. T. (1991) Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72, 1349-1376
73. Kotwal, G. J., and Moss, B. (1988) Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167, 524-537
74. Pickup, D. J., Ink, B. S., Parsons, B. L., Hu, W., and Joklik, W. K. (1984) Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc. Natl. Acad. Sci. U.S.A. 81, 6817-6821
75. Elde, N. C., Child, S. J., Eickbush, M. T., Kitzman, J. O., Rogers, K. S., Shendure, J., Geballe, A. P., and Malik, H. S. (2012) Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 150, 831-841
76. French, A. R., Pingel, J. T., Wagner, M., Bubic, I., Yang, L., Kim, S., Koszinowski, U., Jonjic, S., and Yokoyama, W. M. (2004) Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20, 747-756
77. Unterholzner, L., Sumner, R. P., Baran, M., Ren, H., Mansur, D. S., Bourke, N. M., Randow, F., Smith, G. L., and Bowie, A. G. (2011) Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog. 7, e1002247
78. Ferguson, B. J., Benfield, C. T., Ren, H., Lee, V. H., Frazer, G. L., Strnadova, P., Sumner, R. P., and Smith, G. L. (2013) Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J. Gen. Virol. 94, 2070-2081
79. Kalverda, A. P., Thompson, G. S., Vogel, A., Schröder, M., Bowie, A. G., Khan, A. R., and Homans, S. W. (2009) Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J. Mol. Biol. 385, 843-853
80. Gerlic, M., Faustin, B., Postigo, A., Yu, E. C., Proell, M., Gombosuren, N., Krajewska, M., Flynn, R., Croft, M., Way, M., Satterthwait, A., Liddington, R. C., Salek-Ardakani, S., Matsuzawa, S., and Reed, J. C. (2013) Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc. Natl. Acad. Sci. U.S.A. 110, 7808-7813
81. Postigo, A., Cross, J. R., Downward, J., and Way, M. (2006) Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vacciniainduced apoptosis. Cell Death Differ. 13, 1651-1662
82. Wasilenko, S. T., Stewart, T. L., Meyers, A. F., and Barry, M. (2003) Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100, 14345-14350
83. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., and O'Neill, L. A. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 97, 10162-10167
84. Karplus, P. A., and Diederichs, K. (2012) Linking crystallographic model and data quality. Science 336, 1030-1033